Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Blood|August 21, 2008
IRF-4 functions as a tumor suppressor in early B-cell developmentJaime Acquaviva, Xiaoren Chen, Ruibao RenBiochimica Et Biophysica Acta|September 10, 2008
The multifaceted roles of the receptor tyrosine kinase ROS in development and cancerJaime Acquaviva, Ricky Wong, Al CharestBlood|June 30, 2010
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesisSeung-Hee Jo, Jonathan H Schatz, Jaime Acquaviva, et al.Cytotherapy|August 6, 2026
Nonviral transposon‑engineered stem cells characterization: dose‑dependency between vector copy number and transgene expressionWanzhu Zhao, Brittany Mihelich, Baoyan Fan, et al.Investigational New Drugs|May 21, 2013
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypesJulie C Friedland, Donald L Smith, Jim Sang, et al.Molecular Cancer Research : MCR|February 21, 2014
mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesisJaime Acquaviva, Suqin He, Jim Sang, et al.Targeted Oncology|August 1, 2014
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancerDonald L Smith, Jaime Acquaviva, Manuel Sequeira, et al.Molecular Cancer Therapeutics|September 27, 2012
Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespibJaime Acquaviva, Donald L Smith, Jim Sang, et al.Molecular Cancer Therapeutics|January 9, 2014
Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespibJaime Acquaviva, Donald L Smith, John-Paul Jimenez, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesisHaihao Zhu, Jaime Acquaviva, Pranatartiharan Ramachandran, et al.Pageof 2